Durable CRISPR Stem Cells May Potentially Treat Hemoglobin Disorders (1 of 2) (IMAGE)

American Association for the Advancement of Science (AAAS)

Durable CRISPR Stem Cells May Potentially Treat Hemoglobin Disorders (1 of 2)

Caption

Microscopy image of blood stem cells that will go through CRISPR/Cas9 gene editing in a lab dish. This material relates to a paper that appeared in the Jul. 31, 2019, issue of Science Translational Medicine, published by AAAS. The paper, by O. Humbert at Fred Hutchinson Cancer Research Center in Seattle, WA; and colleagues was titled, "Therapeutically relevant engraftment of a CRISPR-Cas9-edited HSC-enriched population with HbF reactivation in nonhuman primates."

Credit

Kiem lab/Fred Hutchinson Cancer Research Center

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.